iCoreConnect Inc. Stock Price, News & Analysis

iCoreConnect, a cloud-based software and technology company, reported impressive financial growth for 2022. Revenues surged by 60% to $8 million, up from $5 million in 2021, driven by a 20% increase in subscriber count to 30,000. The company's gross profit margin improved to 72% from 68%. CEO Robert McDermott highlighted robust growth across all products and successful launches of additional services. Key endorsements from four state associations boosted credibility, and partnerships with large enterprise clients enhanced market reach. Looking forward, iCoreConnect aims to leverage its strong foundation for continued growth.

iCoreConnect, Inc. (OTCQB: ICCT) announced the endorsement of its iCoreVerify automated insurance verification software by Louisiana Dental Services, Inc. (LDS), a subsidiary of the Louisiana Dental Association (LDA). This marks iCoreConnect's second endorsed product, enhancing workflow efficiency by automating the insurance verification process, saving dental practices 20-40 hours weekly. LDS President, Dr. Bill Hadlock, emphasized the software's capability to significantly reduce verification workload while improving patient care and revenue planning. iCoreConnect continues to showcase its commitment to healthcare innovation through cloud-based solutions aimed at improving profitability for dental practices.

OCOEE, FL, March 7, 2023 – iCoreConnect, Inc. (OTCQB: ICCT) announced the endorsement of its cloud-based ePrescription software, iCoreRx, by the Nebraska Dental Association (NDA). iCoreRx, which includes an add-on for electronically prescribing controlled substances, has over 40 endorsement agreements nationwide. As Nebraska's new ePrescribing law takes effect on January 1, 2024, iCoreConnect aims to help dental practices comply while enhancing workflow and patient safety. The NDA emphasized the benefits of iCoreRx's integration capabilities and cloud-based flexibility. iCoreConnect continues to lead with innovative, compliance-focused solutions in healthcare.

iCoreConnect, Inc. (OTCQB: ICCT) announced the endorsement of its iCoreRx Electronic Prescription software by the Maryland State Dental Association (MSDA), following a previous endorsement for its iCoreVerify software in 2021. This endorsement coincides with new regulations requiring Maryland doctors to send electronic prescriptions for controlled substances starting January 1, 2023. iCoreRx enables secure prescribing from any internet-connected device and integrates with practice management software, enhancing workflow and patient safety. iCoreConnect emphasizes its commitment to improving healthcare efficiency through its comprehensive SaaS solutions.

iCoreConnect (OTCQB: ICCT), a SaaS company focused on healthcare workflow solutions, announced a partnership with Yankee Alliance, a large group purchasing organization with nearly 20,000 members. This collaboration marks iCoreConnect's first with a national GPO, allowing joint marketing of its products to Yankee Alliance's members. The partnership is expected to enhance workflow efficiency in medical practices through cloud-based solutions like iCoreRx ePrescribing and iCoreVerify insurance verification. The partnership aims to save time and money for healthcare providers while improving patient care quality.

iCoreConnect (OTCQB: ICCT), a cloud-based software company, announced the addition of Kevin McDermott from SAP and Harry Travis from The Travis Group to its Board of Directors. This strategic move coincides with the company's business combination agreement with FG Merger Corp., aiming to enhance shareholder value and expand into enterprise markets. McDermott brings 19 years of experience at SAP, while Travis has a strong background in healthcare management, having led operations at CVS Caremark. The company currently offers a suite of 15 SaaS solutions and has over 90 agreements with healthcare associations nationwide.

iCoreConnect, Inc. (OTCQB: ICCT) has launched iCoreVerify+, a new software and concierge service that enhances its existing iCoreVerify automated insurance verification offerings. This service addresses the labor challenges in dental practices by managing the remaining 20% of manual verification work that the automated system can't complete. By freeing up practice staff, iCoreVerify+ allows them to focus on revenue-generating activities and patient care. The company has garnered over 90 product endorsement agreements from state dental and medical associations nationwide.

FG Merger Corp. (FGMC) announced a business combination with iCoreConnect, valuing iCoreConnect at $98 million. This merger will facilitate iCoreConnect's transition from OTC to Nasdaq under the symbol ICCT. Existing FGMC shareholders can convert their equity into preferred stock with a 12% coupon for the first two years. iCoreConnect, a SaaS provider, has seen a 65% revenue CAGR since 2018, projected to achieve $8.1 million revenue in 2022. The merger aims to leverage healthcare technology trends and significant market potential.

iCoreConnect, Inc. (OTCQB: ICCT) announced the endorsement of three products by The PROPS Center, a subsidiary of the Connecticut State Dental Association. The endorsed products include: iCoreRx, a cloud ePrescribing software; iCoreCloud, a HIPAA-compliant encrypted backup solution; and iCoreCodeGenius, which offers rapid ICD-10 coding. The partnership aims to enhance efficiency and operational security for dental practices, with a focus on improving workflow productivity and profitability.